Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
T-Cell Specificity Influences Disease Heterogeneity in Multiple Sclerosis.
Cruciani C, Puthenparampil M, Tomas-Ojer P, Jelcic I, Docampo MJ, Planas R, Manogaran P, Opfer R, Wicki C, Reindl M, Jelcic I, Lutterotti A, Martin R, Sospedra M. Cruciani C, et al. Among authors: puthenparampil m. Neurol Neuroimmunol Neuroinflamm. 2021 Sep 17;8(6):e1075. doi: 10.1212/NXI.0000000000001075. Print 2021 Nov. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34535569 Free PMC article.
BAFF Index and CXCL13 levels in the cerebrospinal fluid associate respectively with intrathecal IgG synthesis and cortical atrophy in multiple sclerosis at clinical onset.
Puthenparampil M, Federle L, Miante S, Zito A, Toffanin E, Ruggero S, Ermani M, Pravato S, Poggiali D, Perini P, Rinaldi F, Gallo P. Puthenparampil M, et al. J Neuroinflammation. 2017 Jan 17;14(1):11. doi: 10.1186/s12974-016-0785-2. J Neuroinflammation. 2017. PMID: 28095856 Free PMC article.
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study.
Prosperini L, Annovazzi P, Boffa L, Buscarinu MC, Gallo A, Matta M, Moiola L, Musu L, Perini P, Avolio C, Barcella V, Bianco A, Farina D, Ferraro E, Pontecorvo S, Granella F, Grimaldi LME, Laroni A, Lus G, Patti F, Pucci E, Pasca M, Sarchielli P; Italian Alemtuzumab Study Group. Prosperini L, et al. J Neurol. 2018 Dec;265(12):2851-2860. doi: 10.1007/s00415-018-9070-x. Epub 2018 Sep 26. J Neurol. 2018. PMID: 30259178
Brain Citrullination Patterns and T Cell Reactivity of Cerebrospinal Fluid-Derived CD4+ T Cells in Multiple Sclerosis.
Faigle W, Cruciani C, Wolski W, Roschitzki B, Puthenparampil M, Tomas-Ojer P, Sellés-Moreno C, Zeis T, Jelcic I, Schaeren-Wiemers N, Sospedra M, Martin R. Faigle W, et al. Among authors: puthenparampil m. Front Immunol. 2019 Apr 10;10:540. doi: 10.3389/fimmu.2019.00540. eCollection 2019. Front Immunol. 2019. PMID: 31024521 Free PMC article.
Altered CSF Albumin Quotient Links Peripheral Inflammation and Brain Damage in MS.
Puthenparampil M, Tomas-Ojer P, Hornemann T, Lutterotti A, Jelcic I, Ziegler M, Hülsmeier AJ, Cruciani C, Faigle W, Martin R, Sospedra M. Puthenparampil M, et al. Neurol Neuroimmunol Neuroinflamm. 2021 Mar 1;8(2):e951. doi: 10.1212/NXI.0000000000000951. Print 2021 Mar. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 33649179 Free PMC article.
Retinal Hyperreflecting Foci Associate With Cortical Pathology in Multiple Sclerosis.
Pengo M, Miante S, Franciotta S, Ponzano M, Torresin T, Bovis F, Rinaldi F, Perini P, Saiani M, Margoni M, Bertoldo A, Sormani MP, Pilotto E, Midena E, Gallo P, Puthenparampil M. Pengo M, et al. Among authors: puthenparampil m. Neurol Neuroimmunol Neuroinflamm. 2022 May 23;9(4):e1180. doi: 10.1212/NXI.0000000000001180. Print 2022 Jul. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 35606113 Free PMC article.
Early Immunotherapy and Longer Corticosteroid Treatment Are Associated With Lower Risk of Relapsing Disease Course in Pediatric MOGAD.
Nosadini M, Eyre M, Giacomini T, Valeriani M, Della Corte M, Praticò AD, Annovazzi P, Cordani R, Cordelli DM, Crichiutti G, Di Rosa G, Dolcemascolo V, Fetta A, Freri E, Gallo P, Gastaldi M, Granata T, Grazian L, Iorio R, Lombardini M, Margoni M, Mariotto S, Matricardi S, Melani F, Nardocci N, Papetti L, Passarini A, Pisani F, Po' C, Puthenparampil M, Ragona F, Savasta S, Siliquini S, Toldo I, Tozzo A, Turco EC, Varone A, Vogrig A, Zuliani L, Bugin S, Rossato S, Orsini A, Cantalupo G, Mancardi MM, Ferilli MAN, Foiadelli T, Sartori S. Nosadini M, et al. Among authors: puthenparampil m. Neurol Neuroimmunol Neuroinflamm. 2022 Nov 29;10(1):e200065. doi: 10.1212/NXI.0000000000200065. Print 2023 Jan. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 36446614 Free PMC article.
61 results